Company Overview of BioIndustry Association
The BioIndustry Association (BIA) is a trade association that promotes biotechnology sector. The company organizes public affairs programs, conference, seminars, trade missions, and committees. It also provides news and publication sources and links to related sites. BIA serves small and medium sized enterprises in United Kingdom. BIA was founded in 1989 and is based in London.
14/15 Belgrave Square
London, SW1X 8PS
Founded in 1989
Key Executives for BioIndustry Association
Compensation as of Fiscal Year 2014.
BioIndustry Association Key Developments
Bioindustry Association Announces Executive Changes, Effective October 30, 2013
Jun 28 13
The BioIndustry Association (BIA) board has elected Edward Hodgkin as its new Chairman, effective October 30, 2013. Dr. Hodgkin succeeds Mr. Tim Edwards, who will formally step down at the October Board meeting following three years as BIA Chairman. Mr. Edwards will remain a member of the BIA Board. Edward Hodgkin has been a non-executive director of the BIA since 2010 and serves as a member of the BIA's Executive Committee. He is a Partner with Syncona Partners, where his role is to create and lead new life science ventures. Prior to joining Syncona in April 2013, he was CEO of Biotica Technology Ltd.
BioIndustry Association Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013
Feb 7 13
BioIndustry Association Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
BioIndustry Association Appoints Harren Jhoti to its Board of Directors
Oct 10 12
Astex Pharmaceuticals Inc. announced that Harren Jhoti, PhD, president and director of Astex Pharmaceuticals, was appointed to the BioIndustry Association Board of Directors. Dr. Harren Jhoti has served as Astex Pharmaceuticals president and member of the Board of Directors since the company's formation in July 2011. He co-founded Astex Therapeutics in 1999 and was chief scientific officer until November 2007 when he was appointed chief executive.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries